Possible scenario
Lab Transparency Dispute
15% Chance
Evidence increasingly points to a possible laboratory exposure, but the epidemiological situation does not yet show broad spread. The main escalation is diplomatic: Washington, Moscow, and the WHO clash over access to samples, logs, and staff interviews.
Initial impacts
- Riskier companies' borrowing costs Up
- Market volatility Up
- 10-year Treasury yield Down
- US dollar Up
Secondary impacts
- Industrials +0.5%
- Healthcare +0.4%
Portfolio impact
S&P 500-0.9%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.